Skip to Main Content

Paper Details

Author Correction: High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.
Nat Med
3
2024
ipilimumab, stage III urothelial cancer
Author NameAffiliation
Niven Mehra
Niven MehraRadboud University Medical Center
Sophie HackingerInivata Ltd.
Kirsten McLayInivata Ltd.
Michiel S van der Heijden
Michiel S van der HeijdenNetherlands Cancer Institute
  • 1 - 6

Datasets

Release 1.2